Innovation in Ireland →
Founder and CEO of Brooks Bell Inc.
CEO and Fund Manager, Renaissance Venture Capital Fund
Managing director, the Foundry Group
Co-Founder and CEO, Wetpaint
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Founder, Young Inventors
Concert Pharmaceuticals is developing a deuterium-modified drugs.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2014, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.